Does the shingles jab slash your risk of dementia?
The trailblazing study will use the data from up to 1.4million NHS patients to test whether its shingles vaccine reduces the ...
British investor eyes 23andMe rescue as it files for bankrupcy
A major British investor is exploring a potential rescue plan for 23andMe, after the consumer genetics company filed for ...
The Business Times5d
AstraZeneca seeks to move past China probe with Beijing R&D hub
HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...
GSK's Omjjara (momelotinib) approved in Singapore as the first treatment indicated for myelofibrosis patients with anaemia
GSK Singapore today announced that Omjjara (momelotinib) has been locally approved for treatment of disease-related ...